POLISH CARDIAC SOCIETY WEB SITE

5th INTERNATIONAL CONGRESS

of the POLISH CARDIAC SOCIETY

Warsaw, 27-29 of September, 2001


MORE INFORMATION ABOUT WARSAW
BACK TO HOMEPAGE LINKS MEDLINE M@IL US NEWS POLISH VERSION

 

SCIENTIFIC SESSIONS SESSIONS OF THE PCS SESSIONS OF THE WORKING GROUPS OF THE PCS PROGRAM

 

SATELLITE SESSIONS

 

SESSION COMPANY TITLE CHAIRPERSONS
8 SERVIER Differences in diagnostic and treatment of patients with coronary artery disease and diabetes mellitus. H. Szwed
J. Dubiel
9 ROCHE Progress of heart failure treatment - new value of CARVEDILOL. M. Dłużniewski
11 BERLIN-CHEMIE Nebivolol - why more than b-blocker? R. Gryglewski
16 PFIZER Coronary heart disease - from prevention to intervention. A. Cieśliński
37 SCHWARZ PHARMA To prolong life or to improve its quality? M. Dłużniewski
41 SERVIER ADVANCE - progress in arterial hypertension therapy. W. Januszewicz
42 ELI LILLY Acute myocardial infarction 2001. W. Rużyłło
44 BAYER Statins - can we expect more? M. Tendera
59 SERVIER Cerebral stroke - underestimated problem of contemporary cardiology. A. Torbicki
H. Kwieciński
60 SANOFI Treatment of acute coronary syndromes - role of modern platelet ADP receptor antagonists. W. Rużyłło
L. Ceremużyński
62 ABBOTT LABORATORIES Cardiovascular diseases - pharmacotherapy of the coming decade. G. Opolski
66 FOURNIER HDL cholesterol and triglycerides - underestimated risk factors of ischaemic heart disease. M. Naruszewicz
M. Dłużniewski
67 AVENTIS Acute coronary syndrome: clinical practice and results of clinical studies. M. Krzemińska-Pakuła
69 MERCK SHARP & DOHME Statins - only cardiological treatment? A. Cieśliński
74 PFIZER How do we treat arterial hypertension in our hospitals? L. Ceremużyński
76 AVENTIS Evidence Based Medicine - method of drug comparison and selection. G. Opolski
90 MERCK SHARP & DOHME Acute coronary syndromes - current strategy of management. W. Rużyłło

 

top of the page